We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$73.1B
AUM Growth
+$2.4B
Cap. Flow
-$1.43B
Cap. Flow %
-1.96%
Top 10 Hldgs %
11.25%
Holding
4,601
New
626
Increased
1,390
Reduced
2,018
Closed
524

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$839M
2
AMZN icon
Amazon
AMZN
+$810M
3
TSLA icon
Tesla
TSLA
+$644M
4
TSM icon
TSMC
TSM
+$546M
5
JNJ icon
Johnson & Johnson
JNJ
+$389M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$891M
2
HD icon
Home Depot
HD
+$441M
3
JPM icon
JPMorgan Chase
JPM
+$335M
4
NVO
Novo Nordisk
NVO
+$317M
5
ASML icon
ASML
ASML
+$315M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Technology 15.51%
3 Consumer Discretionary 11.84%
4 Consumer Staples 10.09%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSTV icon
3926
Plus Therapeutics
PSTV
$26.6M
$25K ﹤0.01%
209
+20
+11% +$3.19K
DCOY
3927
Decoy Therapeutics
DCOY
$2.31M
$25K ﹤0.01%
11
-7
-39% -$24.8K
SNTI icon
3928
Senti Biosciences Holdings
SNTI
$11.5M
$25K ﹤0.01%
+1,770
New +$43.2K
VERO
3929
DELISTED
Venus Concept
VERO
$25K ﹤0.01%
465
+147
+46% +$6.61K
ZKIN icon
3930
ZK International Group
ZKIN
$68.8M
$25K ﹤0.01%
8,600
+5,841
+212% +$25.8K
RNTX
3931
Rein Therapeutics
RNTX
$63.8M
$25K ﹤0.01%
10,564
+1,029
+11% +$3.46K
NXXT
3932
NextNRG Inc
NXXT
$45.2M
$25K ﹤0.01%
4,395
-3,477
-44% -$34.8K
EQ icon
3933
Equillium
EQ
$139M
$24K ﹤0.01%
22,500
+5,300
+31% +$8.5K
IVVD icon
3934
Invivyd
IVVD
$163M
$24K ﹤0.01%
+15,800
New +$43.9K
NNBR icon
3935
NN Inc
NNBR
$279M
$24K ﹤0.01%
16,182
-81,618
-83% -$151K
XWEL icon
3936
XWELL
XWEL
$9.2M
$24K ﹤0.01%
3,305
+165
+5% +$1.83K
SUNE
3937
SUNation Energy
SUNE
$9.65M
-1
Closed -$459K
OPGN
3938
DELISTED
OpGen, Inc
OPGN
$24K ﹤0.01%
867
+279
+47% +$10.3K
MF
3939
DELISTED
Missfresh Limited American Depositary Shares
MF
$24K ﹤0.01%
+13,574
New +$25.7K
NVIV
3940
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$24K ﹤0.01%
10,125
-17,600
-63% -$44.1K
CLWT icon
3941
Euro Tech Holdings
CLWT
$11M
$23K ﹤0.01%
16,400
-3,500
-18% -$5K
FRZA
3942
DELISTED
Forza X1, Inc. Common Stock
FRZA
$23K ﹤0.01%
+17,936
New +$29.9K
SCPX
3943
DELISTED
Scorpius Holdings, Inc.
SCPX
$23K ﹤0.01%
7
+2
+40% +$11K
QTT
3944
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$23K ﹤0.01%
33,580
+400
+1% +$216
SEGG
3945
Sports Entertainment Gaming Global Corp
SEGG
$9.55M
$22K ﹤0.01%
88
+32
+57% +$12.8K
NRSN icon
3946
NeuroSense Therapeutics
NRSN
$16.9M
$22K ﹤0.01%
18,433
-35,867
-66% -$57K
XNET
3947
Xunlei
XNET
$343M
$22K ﹤0.01%
11,943
-100,082
-89% -$157K
NIXX
3948
Nixxy Inc
NIXX
$16M
$22K ﹤0.01%
3,457
-1,456
-30% -$12.7K
TKAT
3949
DELISTED
Takung Art Co., Ltd.
TKAT
$22K ﹤0.01%
39,403
+11,103
+39% +$8.42K
INBS icon
3950
Intelligent Bio Solutions
INBS
$4.35M
$21K ﹤0.01%
44
-1
-2% -$959

Similar funds

Renaissance Technologies's Q4 2022 Portfolio in Review

As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
  • Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
  • Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
  • Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
  • Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
  • Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.